Procter & Gamble Health Limited announces First Quarter Results

Procter & Gamble Health Limited (formerly Merck Limited) announced today its financial results for the quarter ended September 30, 2020. The company has recorded a total revenue of ₹264.0 crores, up 17.2% vs. year ago. The Profit After Tax (PAT) was ₹59.3 crores vs. ₹35.8 crores year ago.

Milind Thatte, Managing Director, Procter & Gamble Health Limited said, "With the country still in the midst of the pandemic, we remain focussed on protecting the health and safety of our employees and partners, ensuring uninterrupted supplies of our quality and affordable vitamins, minerals, supplements and medicinal products for our patients and consumers, and on supporting communities and relief efforts.

"Despite tough market conditions, the Company has made a strong recovery in the first quarter delivering a doubledigit growth driven by portfolio consumerisation, robust business continuity planning and a phased return-to-work initiative. We are very proud of our teams who have been quick and agile to adapt to the changing environment, embracing virtual mediums to ensure continued connect with HCPs and partners, and stepping up on consumer outreach efforts resulting in a positive brand recall across categories. With 'SEHAT' (meaning Health) - our Corporate Social Responsibility (CSR) initiative - the Company continues to step up as a #ForceForGood reaching out to vulnerable populations and supporting relief efforts through partner NGOs."

Shares of Procter & Gamble Health Limited (formerly MERCK LTD.) was last trading in BSE at Rs.5400 as compared to the previous close of Rs. 5324.4. The total number of shares traded during the day was 2345 in over 744 trades.

The stock hit an intraday high of Rs. 5412 and intraday low of 5261. The net turnover during the day was Rs. 12600095.

Source : Equity Bulls

Keywords